BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/15/2025 10:26:28 AM | Browse: 41 | Download: 0
Category |
Endocrinology & Metabolism |
Manuscript Type |
Meta-Analysis |
Article Title |
Role of automated insulin delivery in managing insulin-treated outpatients with type 2 diabetes: A systematic review and meta-analysis
|
Manuscript Source |
Invited Manuscript |
All Author List |
Abul Bashar Mohammad Kamrul-Hasan, Joseph M Pappachan, Lakshmi Nagendra, Nazma Akter, Sweekruti Jena, Deep Dutta and Sunil Nair |
Funding Agency and Grant Number |
|
Corresponding Author |
Joseph M Pappachan, FRCP, MD, MRCP, Professor, Senior Researcher, Faculty of Science, Manchester Metropolitan University, Lower Ormond Street, Manchester M15 6BH, Greater Manchester, United Kingdom. drpappachan@yahoo.co.in |
Key Words |
Automated insulin delivery; Type 2 diabetes; Time in range; Glycated hemoglobin; Meta-analysis |
Core Tip |
This is the first systematic review and meta-analysis specifically targeting the efficacy and safety of automated insulin delivery (AID) systems in patients with type 2 diabetes in the outpatient setting. Analyzing six randomized controlled trials and nine single-arm studies involving 28985 participants, we observed that AID systems enhance glycemic control, evidenced by larger decreases in glycated hemoglobin and improved continuous glucose monitoring metrics compared to standard treatment. AID use increases time in range, reduces time above target glucose, and maintains similar rates of hypoglycemia and serious adverse events. While AID slightly increases the risk of device deficiency, safety is still within acceptable limits. The results indicate short-term effectiveness, but larger and longer-term studies are necessary to confirm the benefits and assess cost-effectiveness. |
Citation |
Kamrul-Hasan ABM, Pappachan JM, Nagendra L, Akter N, Jena S, Dutta D, Nair S. Role of automated insulin delivery in managing insulin-treated outpatients with type 2 diabetes: A systematic review and meta-analysis. World J Diabetes 2025; In press |
 |
Received |
|
2025-06-26 07:12 |
 |
Peer-Review Started |
|
2025-06-30 08:37 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-08-08 07:57 |
 |
Revised |
|
2025-08-14 16:35 |
 |
Second Decision |
|
2025-09-15 02:39 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-09-15 10:26 |
 |
Articles in Press |
|
2025-09-15 10:26 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345